Clinical Trial Update: Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)

View source ↗

Summary

Clinical trial update on using Lipoarabinomannan ELISA for diagnosing tuberculosis in children. The current status of the trial is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: University Hospital, Bonn | Conditions: Tuberculosis | Status: UNKNOWN